Abstract:In order to obtain novel lead compounds with high efficacy, low toxicity and minimum of side effects, using chrysin(5,7-dihydroxyflavone) with very broad biological activities as a starting material, four intermediates 7-O-carboxyalkylation chrysin derivatives (6-9) were synthesized by halogenation and hydrolysis. Four glycine methyl ester derivatives containing chrysin(12-15) were synthesized when the four intermediates above condensated with glycine methyl ester hydrochloride using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride(EDCI), N-hydroxybenzotriazole ( HOBt) and 4-dimethylamiopryidine ( DMAP) as a coupling reagent. And then the corresponding glycine derivatives of chrysin (16-19) were obtained by hydrolysis under conditions of room temperature and pH 10-11. The structures of the target compounds were assigned by H-1 NMR, C-13 NMR, IR and MS. Taking cisplatin as a reference substance, the in vitro antitumor activity tests for target compounds against human hepatocellular carcinoma HepG2 cells and gastric carcinoma MGC-803 cells were carried out by MTT method. The results of primary pharmacological tests indicated that five compounds (14-16, 18, 19) possessed the more potent antitumor activity than chrysin in vitro. What's more, the antitumor activity of compound 18(IC50 =4. 36 mu mol/L) against MGC-803 cells was better than the positive reference compound cisplatin(IC50 =4. 40 mu mol/L).

Syntheses and Anticancer Activities of Glycine Derivatives of Chrysin

Synthesis of Novel Amino Acid Derivatives Containing Chrysin As Anti-Tumor Agents Against Human Gastric Carcinoma MGC-803 Cells

Synthesis of New 7-O-modified Chrysin Derivatives and Their Anti-Proliferative and Apoptotic Effects on Human Gastric Carcinoma MGC-803 Cells

Design, Synthesis and Antiproliferative Activity of Chrysin Derivatives Bearing Triazole Moieties

Synthesis of Chrysin Derivatives and Screening of Antitumor Activity

Design, Synthesis and Biological Evaluation of Chrysin Long-Chain Derivatives As Potential Anticancer Agents

Design, Synthesis and Biological Evaluation of Chrysin Benzimidazole Derivatives As Potential Anticancer Agents

Synthesis and Evaluation of Antitumour Activity in Vitro and in Vivo of Chrysin Salicylate Derivatives

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Synthesis and In Vitro Anticancer Evaluation of Chrysin Containing Hybrids and Other Chrysin Derivatives

Synthesis of glycyrrhetinic acid C3 and C30 derivatives and their antitumor activities in vitro

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Design, Synthesis and Evaluation of Structurally Diverse Chrysin-Chromene-spirooxindole Hybrids As Anticancer Agents.

Chiral Gossypol Derivatives: Evaluation of Their Anticancer Activity and Molecular Modeling.

Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.

Synthesis and bioactivity evaluation of 3-phenyl-1H-pyrazoline derivatives

Synthesis and Evaluation in vitro of Dihydrothiophenopyridine-Chalcone Derivatives as Anticancer Activity Agents

Rational Synthesis and Preliminary Anti-cancer Activities of 18Β-Glycyrrhetinic Acid Derivatives Containing Pyridinecarboxamide

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin